Omar M. Abu Saleh, M.B.B.S.

Attending
Mayo Clinic

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-4) The Clinical Characteristics and Outcomes of Combination Therapy on Methicillin-susceptible Staphylococcus aureus Bacteremia: A 5-Year Experience
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-59) Clinical predictors of ICU admission in patients with invasive Pneumococcal blood stream infection: a review of 10-year single-center experience
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-74) Characteristics and Clinical Outcomes of Lyme Arthritis: A Single-Center, Retrospective Study
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1242) Beta-Lactam Therapeutic Drug Monitoring in the Hematology/Oncology Population
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1563) Unraveling a good paradox - Tertiary center experience with Good syndrome and its infectious complications; Insights from 32 cases identified through 2024
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1774) Clinical presentation of Cutaneous Leishmaniasis (CL) in returning travelers
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1849) Beta-Lactam Therapeutic Drug Monitoring in Outpatient Antimicrobial Therapy (OPAT) Patients
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1935) Persistent Candidemia: Predictors and Outcomes in a Multicenter Matched Analysis
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-2152) Adenovirus Viremia in Adults: Clinical Syndromes, Risk Factors, and Outcomes
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET